Literature DB >> 8994041

Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein.

C I Lasmézas1, J P Deslys, O Robain, A Jaegly, V Beringue, J M Peyrin, J G Fournier, J J Hauw, J Rossier, D Dormont.   

Abstract

The agent responsible for transmissible spongiform encephalopathies (TSEs) is thought to be a malfolded, protease-resistant version (PrPres) of the normal cellular prion protein (PrP). The interspecies transmission of bovine spongiform encephalopathy (BSE) to mice was studied. Although all of the mice injected with homogenate from BSE-infected cattle brain exhibited neurological symptoms and neuronal death, more than 55 percent had no detectable PrPres. During serial passage, PrPres appeared after the agent became adapted to the new host. Thus, PrPres may be involved in species adaptation, but a further unidentified agent may actually transmit BSE.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8994041     DOI: 10.1126/science.275.5298.402

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  148 in total

1.  Prion proteins and the gut: une liaison dangereuse?

Authors:  A N Shmakov; S Ghosh
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

2.  Prion infection impairs the cellular response to oxidative stress.

Authors:  O Milhavet; H E McMahon; W Rachidi; N Nishida; S Katamine; A Mangé; M Arlotto; D Casanova; J Riondel; A Favier; S Lehmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 3.  Transgenesis applied to transmissible spongiform encephalopathies.

Authors:  Jean-Luc Vilotte; Hubert Laude
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

4.  Theoretical modeling of prion disease incubation.

Authors:  R V Kulkarni; A Slepoy; R R P Singh; D L Cox; F Pázmándi
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

5.  Virus-like interference in the latency and prevention of Creutzfeldt-Jakob disease.

Authors:  Laura Manuelidis; Zhi Yun Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-11       Impact factor: 11.205

6.  RNA aptamers specifically interact with the prion protein PrP.

Authors:  S Weiss; D Proske; M Neumann; M H Groschup; H A Kretzschmar; M Famulok; E L Winnacker
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

7.  Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.

Authors:  N Kellershohn; M Laurent
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

8.  Mutant prion protein D202N associated with familial prion disease is retained in the endoplasmic reticulum and forms 'curly' intracellular aggregates.

Authors:  Yaping Gu; Susamma Verghese; Sharmila Bose; Maradumane Mohan; Neena Singh
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

9.  Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type.

Authors:  Samia Hannaoui; Layal Maatouk; Nicolas Privat; Etienne Levavasseur; Baptiste A Faucheux; Stéphane Haïk
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

10.  Progress and problems in the biology, diagnostics, and therapeutics of prion diseases.

Authors:  Adriano Aguzzi; Mathias Heikenwalder; Gino Miele
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.